UPDATE : Tuesday, July 23, 2019
상단여백
Researchers develop device administering drugs with infrared rays
A research team consisting of researchers from Seoul National University (S...
by Lee Han-soo  |  2019-06-12 16:54
라인
Daewoong’s botulinum toxin hits a snag in European approval
Daewoong Pharmaceutical is expected to face a delay in obtaining European a...
by Jeong Sae-im  |  2019-06-12 16:50
라인
Vaginal microbiome in pregnant women can predict premature birth
Vaginal microbiome in pregnant women could be used as an indicator to predi...
by Song Soo-youn  |  2019-06-12 14:43
라인
Novo Nordisk’s Saxenda dominates local obesity market
Novo Nordisk's Saxenda (ingredient: liraglutide), the world's first...
by Lee Han-soo  |  2019-06-12 14:16
라인
Atopic dermatitis patients demand reimbursement for Sanofi’s biological drug
Korean patients with severe atopic dermatitis gathered in front of the Nati...
by Kim Yun-mi  |  2019-06-12 13:29
라인
[Startups to Watch] 'Noul aims to become major player in eradicating malaria'
Malaria, a mosquito-borne disease, is one of the most common infectious dis...
by Lee Han-soo  |  2019-06-12 11:01
라인
US expert sees need for new treatment models for Alzheimer’s disease
Alternative treatments can help dementia patients psychologically, if not p...
by Lee Han-soo  |  2019-06-11 17:53
라인
Forxiga prevents kidney disease in diabetes patients
AstraZeneca’s sodium-glucose cotransporter-2 (SGLT2) inhibitor Forxiga (ing...
by Kim Yun-mi  |  2019-06-11 15:40
라인
3 of 10 cancer survivors feel discriminated at work: survey
Three out of 10 Korean cancer survivors experienced workplace discriminatio...
by Kwak Sung-sun  |  2019-06-11 14:26
라인
‘Medytox got review suspension in China only once’
Korean botulinum toxin maker Medytox said the Chinese regulator ordered the...
by Jeong Sae-im  |  2019-06-11 10:50
라인
[ASCO 2019] Imfinzi 1st IO to report 3-year OS in unresectable stage III NSCLC
Chicago, Ill -- AstraZeneca‘s Imfinzi (Ingredient: durvalumab) has demonstr...
by Lee Han-soo, KBR Correspondent  |  2019-06-11 08:00
라인
SCM, T&R to develop tissue regeneration, therapy products
SCM Life Science and T&R Biofab have agreed to collaborate on the research ...
by Lee Han-soo  |  2019-06-10 17:50
라인
Regulator OKs AstraZeneca's Fasenra as additional therapy for severe asthma
AstraZeneca's Fasenra (ingredient: benralizumab) gained approval as an ...
by Lee Han-soo  |  2019-06-10 17:10
라인
CJ HealthCare to invest ₩100 billion in new IV fluid factory
CJ HealthCare, a subsidiary of Kolmar Korea, said Monday it would invest 10...
by Jeong Sae-im  |  2019-06-10 16:17
라인
'Big data is overrated, vulnerable to contamination'
Big data, the key to medical technologies in the future, is being regarded ...
by Kim Eun-young  |  2019-06-10 16:15
라인
Hanmi unveils strong pipeline candidates in US diabetes meet
Hanmi Pharmaceutical said that it has confirmed its global competitiveness ...
by Lee Han-soo  |  2019-06-10 15:07
라인
Medytox’ botulinum toxin may face approval delay in China
Korean botulinum toxin maker Medytox may likely suffer a delay in Chinese r...
by Jeong Sae-im  |  2019-06-10 13:55
라인
State health insurance agency, WHO seeks cooperation
National Health Insurance Service (NHIS) President Kim Yong-ik held talks w...
by Kim Eun-young  |  2019-06-07 16:27
라인
Kolon TissueGene CEO resigns
Kolon TissueGene, a subsidiary of Kolon Life Science, said Co-CEO Lee Woo-s...
by Jeong Sae-im  |  2019-06-07 15:35
라인
Expat workers left behind in mandatory health insurance program
Foreigners who stay longer than six months in Korea are obliged to subscrib...
by Kim Eun-young  |  2019-06-07 15:27
여백
여백
여백
Back to Top